Molecular Target Therapy – Towards Curative Regimen: A 20-Year Experience in the Treatment of Acute Promyelocytic Leukemia (APL) in the Shanghai Institute of Hematology

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-2-s1-a1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mouse Model for Early Acute Promyelocytic Leukemia (APL)

Science-Business eXchange
2011English

Target Acquisition and Acute Promyelocytic Leukemia

Journal of Clinical Investigation
Medicine
1999English

Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Differentiation Therapy in Acute Myelogenous Leukemia (Non-Apl)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Progress in the Treatment of Acute Promyelocytic Leukemia: Optimization and Obstruction

International Journal of Hematology
Hematology
2014English

Epidemiology and Treatment of Acute Promyelocytic Leukemia in Latin America

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2011English

Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia

Case Reports in Hematology
2017English

A Case of Neutropenic Enterocolitis During the Treatment of Acute Promyelocytic Leukemia

Nihon Shuchu Chiryo Igakukai zasshi
1998English

Treatment of Acute Promyelocytic Leukemia for Older Patients

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy